A Paradigm Shift in Clinical Research and Education: The p-value Controversy and the End of Statistical Significance?
Join us to:
Understand the rationale behind the American Statistical Association (ASA) statement that
“No single index [i.e., p-value] should substitute for scientific reasoning.”
Discuss the role that p-values have had on reproducibility and replication and the proposed remedies.
Apply alternative remedies for dealing with uncertainty in clinical research and education.
Tuesday, April 7, 2020, 8:30AM-11:30AM
Jean Mayer Human Nutrition Research Center on Aging (HNCRA)
711 Washington Street,
Boston, MA
Distinguished speakers will include:
John P.A. Ioannidis, MD, DSc
C.F. Rehnborg Chair in Disease Prevention and Professor at Stanford University Author of
“Why Most Published Research Findings are False,” accessed more than three million times and is “perhaps also the most currently cited physician.”
David Allison, PhD
Dean and Provost of the Indiana University School of Public Health Author of
“A Tragedy of Errors: Mistakes in Peer-reviewed Papers are Easy to Find but Hard to Fix, Report.”
David Harrington, PhD
Professor of Biostatistics, Emeritus, Harvard T.H.Chan School of Public Health Co-Author of the 2019 New England Journal of Medicine article,
“New Guidelines for Statistical Reporting in the Journal”
Allen Schirm, PhD
Recently retired from Mathematica Policy Research Co-author of the 2019 The American Statistician editorial, “Moving to a World Beyond ‘p<0.05’.”
All are welcome to attend, especially clinician researchers and investigators leading clinical trials, and statisticians working with and educating clinical investigators.
